title: Cholesterol, cholesterol lowering agents/statins, and urologic disease: part II--do you know your Framingham Risk Score?
authors.affiliation: University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Moyad
authors.forename: Gregory S
authors.initials: GS
authors.lastname: Merrick
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000209:etiology; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications* / Q000175:diagnosis* / Q000517:prevention & control; D006973:Hypertension / Q000150:complications / Q000517:prevention & control; D008875:Middle Aged; D010353:Patient Education as Topic; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D040242:Risk Reduction Behavior; D012907:Smoking / Q000009:adverse effects
chemical_list: D008076:Cholesterol, HDL; D002784:Cholesterol